Immunovant
IMVT
$29.39
Share price
-1.04%
Change (1 day)
63.73%
Change (1 year)
Categories
Immunovant (IMVT) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $32.1 M
According to Immunovant's latest financial reports the company's total liabilities are $32.1 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Immunovant - Total liabilities on balance sheet (from 2019 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-03-31 | $43.34 M | -5.24% |
| 2022-03-31 | $45.73 M | 117.71% |
| 2021-03-31 | $21 M | 37.15% |
| 2020-03-31 | $15.31 M | |
| 2018-12-31 | $0.38 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -13.03% | 🇺🇸 USA |